Global Liver Institute
News
GLOBAL LIVER INSTITUTE
GLI Statement on the CMS 2026 Medicare Advantage and Part D Final Rule on Anti-Obesity Medication Coverage
On Friday, April 4, 2025, the U.S. Centers for Medicare and Medicaid (CMS) released the 2026 Medicare Advantage and Part D Final Rule and decided not to finalize the proposed rule to extend obesity treatment coverage to Medicare and Medicaid beneficiaries.
Administration focuses on health program consolidations and terminates more federal employees, leaving some key health programs without staff – Liver Health Policy Update
Medicaid cuts are still under consideration in Congress as the House pushes for the Senate to accept its version of a budget reconciliation package.
Advances in Treatment, Diagnosis, and Care – Liver Cancer News
Join us on Monday, April 21, 2025, at 3:00 PM PST | 6:00 PM EST for GLI’s Liver Cancer Lessons: Liver Disease Prevention Through Nutrition, an educational webinar that discusses the impact nutrition has on liver health.
Meet Our New Fatty Liver Disease Program Director! – Fatty Liver Disease News
Global Liver Institute is excited to announce the appointment of Dr. Sharon Jaycox as the new Fatty Liver Disease Program Director.
MiKayla Chapman’s Experience with the Rare Science Fairs – Pediatric and Rare Liver Diseases News
Growing up in rural Mississippi, MiKayla believed that opportunities in science were reserved for people from well-connected backgrounds.
Proactive Protection of the Liver Health of Asian Americans
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV) that can cause long-term (chronic) disease. Chronic hepatitis B can lead to serious liver damage – including scarring (cirrhosis), liver failure, and even liver cancer.
Global Liver Institute and King’s College Hospital NHS Foundation Trust Launch First UK-Based Advanced Advocacy Academy to Strengthen Liver Health Education and Awareness
Global Liver Institute (GLI) and King’s College Hospital NHS Foundation Trust (KCH) are proud to announce the first Advanced Advocacy Academy (A3) in the United Kingdom, an innovative program dedicated to increasing education, awareness, and advocacy for liver health.
Congress grapples with budget and appropriations while the administration eliminates funding for health programs and terminates federal employees. – Liver Health Policy Update
The situation in Congress remains unclear as the House budget resolution calls for possible significant Medicaid cuts, while the Senate attempts to steer clear of policies reducing Medicaid and/or Medicare benefits.
Beyond the Diagnosis: Stories, Breakthroughs & Global Action – Fatty Liver Disease News
As of January 2025, major changes to Medicare Part D under the Inflation Reduction Act are now in effect, making prescription drugs more affordable for millions of patients.
How to Stay Engaged Beyond Rare Liver Diseases Month – Pediatric and Rare Liver Diseases News
February is Rare Liver Diseases Month! This year, our campaign is shining a spotlight on Rare and Rural.
Advances in Liver Cancer Treatment & Research – Liver Cancer News
Liver cancer continues to be a growing public health concern, with new research and treatment innovations shaping the future of care. This newsletter brings you the latest advancements in the field, including promising therapies, diagnostic breakthroughs, and discussions on the rising impact of metabolic and alcohol-related liver diseases. Stay informed with expert insights and emerging strategies that could improve patient outcomes.
How the Hepatitis C Cure Affects Other Chronic Conditions
Hepatitis C infection is a chronic infection of the liver by the hepatitis C virus (HCV) that continues to affect millions of people across the globe. Left untreated, infection with hepatitis C leads to worsening liver damage and puts the body in distress, which can lead to brain fog, abdominal pain, and internal bleeding.